兩連板的華資實業(600191.SH):主業以委託加工原糖及貿易銷售為主
格隆匯3月27日丨連續2個漲停的華資實業(600191.SH)發佈公告稱,經公司自查並向控股股東、實際控制人核實,確認不存在應披露而未披露的重大信息。
公司生產經營正常,未發現對公司股票交易價格可能產生重大影響的媒體報道或市場傳聞。
公司生產經營正常,主業以委託加工原糖及貿易銷售為主,市場環境或行業政策沒有發生重大調整、生產成本和銷售等情況沒有出現大幅波動、近期沒有簽訂或正在磋商洽談重大合同、無產業轉型升級投資新項目等。
公司主要業務收入來源於投資收益。經公司財務部門初步測算,預計2019年年度實現歸屬於上市公司股東的淨利潤與上年同期相比,將實現扭虧為盈,實現歸屬於上市公司股東的淨利潤2735萬元左右。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.